Host-Based Prognostic Biomarkers to Improve Risk Stratification and Outcome of Febrile Children in Low- and Middle-Income Countries.

Balanza, Núria; Erice, Clara; Ngai, Michelle; Varo, Rosauro; Kain, Kevin C; Bassat, Quique

Balanza, Núria; Erice, Clara; Ngai, Michelle; Varo, Rosauro; Kain, Kevin C; Bassat, Quique.

Afiliação

Balanza N; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
Erice C; Sandra-Rotman Centre for Global Health, Toronto General Research Institute, University Health Network-Toronto General Hospital, Toronto, ON, Canada.
Ngai M; Tropical Disease Unit, Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Varo R; Sandra-Rotman Centre for Global Health, Toronto General Research Institute, University Health Network-Toronto General Hospital, Toronto, ON, Canada.
Kain KC; Tropical Disease Unit, Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Bassat Q; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Front Pediatr ; 8: 552083, 2020.

Article em En | MEDLINE | ID: mdl-33072673

Palavras-chave

angiopoietin-2 (Ang-2); febrile syndrome; prognostic host-biomarkers; risk stratification; sepsis; severe infection; soluble triggering receptor expressed on myeloid cells 1 (sTREM-1)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google